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SUMMARY.-An analysis of 101 cases ofbreast carcinoma occurring in patients
under 35 years of age is presented with details of clinical stage, site, size and
histological appearances of the tumour. Various factors are correlated with
survival and the prognosis of the patient under 35 years is found to be closely
related to the histological appearances of the tumour, which are reflected in
the clinical stage at presentation. The question of treatment of carcinoma of
the breast in the young woman is discussed.
THE treatment of breast cancer at any age or at any stage is a subject
constantly under discussion. Opinions differ widely and categorical statements
are made often without any foundation. It is unlikely that any agreement will
be reached until much more is known about the aetiology of the disease.
At the present time therapy must be based on the knowledge available; this
can be obtained by a study of the results of treatment retrospectively and it
should be possible to give a reasoned opinion when confronted with a patient
with breast cancer. Perhaps the two most difficult problems which face the
clinician are the diagnosis of breast tumours in young patients and the decision
as to the best plan of treatment. This is particularly important in patients
under the age of35 years who fall into a special category. They may be unmarried
and therefore naturally opposed to the removal of a breast. They may be preg-
nant, when the problem of treatment is particularly difficult or they may have a
family and have every reason to hope therefore for a long period of survival.
Carcinoma ofthe breast in the young is regarded by some authors as having a
poor prognosis (Ewing, 1940; Taylor and Wallace, 1947) and others that it is
no worse than in other age groups (de Cholnoky, 1943; Cade, 1948; Bloom,
1950; MacDonald and Wilcox, 1956). It was universally recognized that breast
cancer during pregnancy or lactation had a poor prognosis and was for a long
time considered to be inoperable (Gross, 1880). However, Harrington (1937)
showed that the prognosis is not always as bad as it had been considered to be in
the past, and Dargent and Mayer (1948) noted that in cases with uninvolved
nodes the prognosis was certainly better than in cases uncomplicated by pregnancy
or lactation. Smithers et al. (1952) reported 9 cases of breast cancer occurring
concurrently with pregnancy and while 7 failed to survive more than 18 months,
2 remained alive and well, 1 without recurrence at 5 years, the other at 10 years.
While opinions differ fundamentally with regard to treatment, and although
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in many cases it is not of importance since the survival time is so short, never-
theless an attempt must be made to give the best possible treatment to those
patients who are in fact going to survive for more than 5 years. A retrospective
appraisal ofpatients under 35 years of age treated at the Royal Marsden Hospital
over the last 20 years was undertaken in order to formulate some conclusions as
to the best treatment for these patients.
MATERIAL
One hundred and fifty-eight cases of breast carcinoma in women under 35
years of age were seen at the Royal Marsden Hospital in the years 1947 to 1966.
One hundred and one ofthese cases have been retrospectively reviewed in clinical
and pathological detail.
The cases were at various stages of their disease, some requiring initial treat-
ment, and others evaluation following treatment elsewhere. As was inevitable
with referrals from other centres, both in this country and abroad, clinical and
pathological details were sometimes incomplete and where possible these were
obtained from the referring centre. However, 54 cases had to be excluded
because pathological material could not be obtained for reassessment. Three
other cases were lost to follow-up within 1 to 3 years, and were excluded.
RESULTS
Age and age group
The age at which initial treatment was carried out is shown in Table I.
Approximately 50% were under 32 years of age.
TABLE I.-Distribution of Cases According to Age
Age in years
, ~~~~~~~~~~~A
23 24 25 26 27 28 29 30 31 32 33 34
Number of cases 4 4 1 3 6 4 6 11 14 14 17 17
Table II denotes breakdown into age groups with 5 and 10 year survival
figures.
TABLE II.-Details of 101 Cases under 35 Years with Survivals of Age Groups
of Cases Followed 5 and 10 Years
Number Number Number Number
Number of followed surviving followed surviving
cases 5 years 5 years 10 years 10 years
Total. . . . 101 92 . 33 . 79 14
No. under 26 years . 9 . 8 . 2 . 8 . 2
No. 26-30 years . 28 26 . 7 . 25 . 2
No. 31-34 years . . 64 . 58 . 24 . 46 . 10
Family history
In many cases no details of family history were recorded or available but
17 ofthis series had near relations with breast cancer ofwhom 6 were the patient's
mother, 7 were maternal relations, 2 were sisters and 2 were paternal relations.
Details of the ages of these relatives at presentation and their follow-up are
inadequate for further study, but it is of interest that 2 patients in this series,
aged 31 and 30, had mothers whose breast cancer was treated at 50 and 54
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respectively. A 28 year old patient in this group had a mother and maternal
grandmother treated when they were 54 and 45 respectively.
Marital status
Of the 101 cases, 79 were married and 22 single. There is little difference in
survival in the two groups (Table III).
TABLE III.-Details of Married and Single Cases withFollow-up and Survivals
at 1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No. NO
fol- sur- fol- sur- fol- sur- fol- sur- fol- sUI lowed viving lowed viving lowed viving lowed viving lowed vivi] Marital 1 1 2 2 3 3 5 5 10 10
state Total year year years years years years years years years yea
arried . 79 . 79 . 67 . 79 . 55 . 78 . 40 . 72 . 25 . 61 . 10 ngle . . 22 . 22 . 20 . 22 . 16 . 22 . 14 . 20 . 8 . 18 . 4
D.
r-
ng
%rs
Parity
An obstetric history was not recorded in 10 cases. Thirty-four patientshad
never been pregnant and of the remaining 57, 4 had miscarried in the first 3
months and are regarded as being nulliparous in the survival figures of Table IV.
Nullir
Parou
TABLE IV.-Details of Nulliparous and Parous Cases with Follow-up and
Survivals at 1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol-
lowed viving lowed viving lowed viving lowed viving lowed vi
1 1 2 2 3 3 5 5 10
Total year year years years years years years years years y
?arous . 38 . 38 . 35 . 38 . 31 . 37 . 24 . 34 . 12 30
1S . . 53 . 53 . 42 . 53 . 30 . 53 . 23 . 49 . 15 . 41 .
No.
sur-
iving
10
rears
6
5
Table V compares survival in parous groups.
Nc
chi]
1
2
3 and
Total
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TABLE V.-Details ofParous Cases with Follow-up and Survivals at 1, 2,
3, 5, and 10 Years
No. No. No. No. No. No. No. No. No. I
fol- sur- fol- sur- fol- sur- fol- sur- fol- E
No. lowed viving lowed viving lowed viving lowed viving lowed v .of of 1 1 2 2 3 3 5 5 10 ldren cases year year years years years years years years years 3
23 . 23 . 19 . 23 . 13 . 23 . 11 . 22 . 6 . 18
. 20 20 15 20 10 20: 5 18: 4 16: Ilover .10 .10 . 8 .10 . 7 .10 . 7 . 9 . 5 . 7
.53 .53 .42 .53 .30 .53 .23. 49 .15 .41.
TABLE VI.-Details of Breast Feeding and Non-breast Feeding Cases with
Follow-up and Survivals at 1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol-
lowed viving lowed viving owed viving lowed viving lowed v:
1 1 2 2 3 3 5 5 10
Total year year years years years years years years years 3
No.
sur-
viving
10
years
2
2
1
5
No.
sur-
riving
10
years
feeding . 39 . 39 32 . 39 . 21 . 39 . 16 . 37 . 10 . 33 . 6 Non-breast
feeding . 9 . 9 . 7 . 9 . 7 . 9 . 6 . 8 . 5 . 5 . 0
MS
Sih
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Breast feeding
Of the 55 parous cases, 39 had breast fed at least once, although details of
duration of feeding were unrecorded. Nine cases had not breast fed and for
the remaining 7 cases no details were recorded.
TABLE VIJ.-Details of 17 Patients with Breast Carcinoma Associated with
Pregnancy or Lactation
Delay Stage Treatment
Before 1 yr Late . Radiotherapy at 20 weeks of
pregnancy pregnancy followed by radi-
cal mastectomy
5 mth . Late . Partialmastectomyand radio-
therapy at 5 mth and
hysterectomy
During 4 mth
Pregnancy
1 yr
Early . Total mastectomy only at 24
wk of pregnancy
Late . 9 mth post-partum partial
mastectomy and radiothe-
rapy
Prognosis
N.S.R. 3 yr 4 mth
Dead 3 mth
N.S.R. 5yr 11 mth
Dead I yr 3 mth
1st Trimester . 5 mth . moderate . At 5 mth ofpregnancy partial
mastectomy, radiotherapy
and total mastectomy
2 yr Early . 17 mth after delivery radical
mastectomy and radiothe-
rapy
2nd Trimester 3 mth . Early . Radical mastectomy at 6 mth
of pregnancy and after de-
livery radiotherapy
3rd Trimester 10 mth Late . 9 mth after delivery, radio-
therapy and radical mast-
ectomy
6 mth Late 6 mth after delivery radical
mastectomy and radiothe-
rapy
Post-partum 6 wk Late 15 wk after delivery, radical
and mastectomy and radiothe-
lactation rapy
14 mth Late 14 mth after delivery radical
mastectomy and radiothe-
rapy
< 1 mth Early 4 mth after delivery, radical
mastectomy and radiothe-
rapy
6 mth Late 10 mth after delivery, radical
mastectomy and radiothe-
rapy
Pregnancy
following
treatment
<1 mth Early . Pregnancy 4 yr after radical
mastectomy
2 yr Moderate Pregnancy 2i yr after radical
mastectomy and radiothe-
rapy terminated
5 mth Late Pregnancy 2 mth after radical
mastectomy whilst having
radiotherapy terminated
6 mth . Late Pregnancy 2 mth following
radical mastectomy whilst
receiving radiotherapy.
Miscarriage at 10 wk,
within 3 wk pregnant again
and terminated at 6 wk
Dead 5 yr 3 mth
Alive 13 yr 7 mth
Alive 4 yr
Dead I yr I mth
Dead 11 mth
Dead I yr 2 mth
Dead 1 mth
Dead 2 yr 2 mth
Dead 6 mth
N.S.R. 15 yr 4 mth
Alive 3 yr 8 mth
Dead 2 yr 11 mth
Alive 6 yr 5 mth
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Pregnancy and lactation
Seventeen cases in this category were divided into groups depending on
whether the lump was noticed before, during or soon after pregnancy, or whether
the patient had become pregnant following treatment. The results are shown
in Table VII. Delay in this table refers to the period between the discovery of
the lump or first symptom and the institution of treatment. For an explanation
of stage see below under Clinical Stage.
Both cases with lumps found before pregnancy were in the late clinical stage
and both had involved nodes.
Of the 7 cases in which lumps were discovered during pregnancy all were
allowed to term, 2 receiving initial treatment whilst pregnant (radical mastectomy
followed by post-partum radiotherapy); 3 cases survived 5 years. One of these
cases, despite a delay ofnearly 20 months, had no histological evidence ofaxillary
metastases and is alive 13 years and 7 months later.
In 4 cases a lump was discovered during lactation; all had involved nodes and
were dead within 2 years 2 months.
Four cases became pregnant following treatment. Two of these were
terminated whilst receiving post-radical mastectomy radiotherapy, one dying
within 3 years, the other alive 6 years and 5 months later. The other 2 who
became pregnant 24 years and 4 years after treatment (radical mastectomy with
post-operative radiotherapy, and radical mastectomy only, respectively) were
allowed to go to term and are alive 3 years 8 months and 15 years 4 months
later respectively.
Delay
The period of delay between the discovery of a lump by the patient (or the
first symptom) and the start oftreatment was recorded in 99 cases and is tabulated
(Table VIII).
TABLE VIII.-Delay Before Treatment in 99 Cases
Delay in . Less than . 12 months and
months 1month 1. 2. 3. 4 .5 .6 .7 .8.9.10.11. over
No. of cases . 25 .15 .18. 10. 2 .5. 6. 2 .1.1. 1. 2. 11
In the 25 cases with a delay period ofless than one month, 15 cases had histo-
logical evidence of axillary node metastases. Twenty-five patients had a delay
period of 3-7 months and 19 of these cases had histologically involved nodes.
Of 11 patients with a delay of 1 year or more, 9 had histologically involved
nodes.
Survival figures of the three groups are shown in Table IX.
TABLE IX.-Details of Delay Periods with Follow-up and Survival at
1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol- sur-
Delay No. of lowed viving lowed viving lowed viving lowed viving lowed viving
(months) cases I yr I yr 2 yr 2 yr 3 yr 3 yr 5 yr 5 yr 10 yr 10 yr
<1 . 25 . 25 . 21 . 25 20 . 25 . 15 23 . 10 16 . 2
3-7 . . 25 . 25 . 20 . 25 16 25 14 . 23 . 6 . 22 . 2
12 and over . 11 .11 .10 .11. 7 .11. 4. 9. 2. 8. 1
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Clinical presentation
Ninety-five patients felt a lump in the breast (4 lumps being tender), 3 felt
a lump in the axilla and 3 presented with nipple discharge (one serosanguinous,
2 serous). In no case was the lump discovered at a routine medical examination.
The clinical diagnosis at hospital level was:
(a) Carcinoma 92 cases
(b) Fibro-cystic disease 5 cases
(c) Duct papilloma 2 cases
(d) Duct carcinoma 1 case
(e) Fibroadenoma 1 case
Clinical stage
Accurate clinical staging was not possible in all cases, but an attempt has
been made to regroup the cases according to the T.N.M. criteria of the U.I.C.C.
classification. Where appropriate clinical information was not available this was
deduced where possible from pathological information. This was often the
case in respect of tumour size and therefore TI or T2 NO MO group (Stage I or
" early ") only includes tumours of 5 cm. or less. Some of these may have been
recorded clinically as T3. Because the information about the size of the tumour
and the state of the axillary nodes was not uniformly clinical or pathological,
this grouping is largely artificial and not strictly comparable with clinical T.N.M.
observations.
Cases have therefore been grouped as follows:
Stage I (early): TI NO MO
T2 NO MO
Stage II (intermediate): TI Ni MO
T2 Ni MO
Stage III (late): TI N2 or N3 MO
T2 N2 or N3 MO
T3 NO, NI, N2 or N3 MO
T4 NO, NI, N2 or N3, MO
See Table X for staging and survival figures.
TABLE X.-Clinical Staging of 101 Cases with Follow-up and Survivals
at 1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol- sur-
No. of lowed viving lowed viving lowed viving lowed viving lowed viving
Stage cases I yr I yr 2 yr 2 yr 3 yr 3 yr 5 yr 5 yr 10 yr 10 yr
Early. . 17 17 16 . 17 16 . 16 13 . 14 . 11 . 9 . 6
Intermediate 43 . 43 . 42 43 . 36 . 43 . 28 . 39 . 15 . 34 . 5
Late . . 41 41 . 29 41 19 . 41 . 13 . 39 . 7 . 36 . 3
Total. .101 .101 .87 .101 .71 .100 .54 .92 .33 .79 .14
Table XI shows the clinical staging of married and single patients.
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TABLE XI.-Marital State and Clinical Staging
Marital state Early Intermediate Late
Total No. 17 . 43 . 41
Married 79 . 13 . 36 . 30
Single . 22 4 . 7 . 11
Size of tumour
Where the measurement of the tumour was not recorded in either clinical or
pathological examination, an approximation was made on the description of the
growth. In 13 cases no approximation of size was possible. Table XII denotes
survival figures in the remaining 88 cases.
TABLE XII.-Size of Tumour in 88 Cases with Follow-up and Survival Figures
at 1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol- sur- Size lowed viving lowed viving lowed viving lowed viving lowed viving
(cm.) No. I yr 1 yr 2yr 2yr 3yr 3yr 5yr 5yr 10yr 10yr
< 2 . . 17 . 17 . 17 17 . 17 . 16 . 15 . 14 . 13 9 . 8
2-5 . 41 41 . 38 . 41 . 31 . 41 24 . 37 9 . 31 . 0
5-10 . . 24 . 24 . 14 . 24 . 9 . 24 3 . 23 . 3 21 . 1
>10. . 6. 6. 3. 6. 1. 6. 1. 6. 1. 6. 1
Total. .88 .88 .72 .88 .58 .87 .43 .80 .26 .67 . 10
Site and laterality of tumour
Fifty-three tumours were in the right breast and 48 tumours in the left breast.
In 24 cases there were no details as to the site ofthe tumour in the breast. Table
XIII shows the site and survival in the remaining 77 cases.
TABLE XIII.-Site of Tumour in 77 Cases with Follow-up and Survival at
1,2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol- sur-
lowed viving lowed viving lowed viving lowed viving lowed viving Site No. I yr I yr 2yr 2yr 3yr 3yr 5yr 5yr 10yr 10yr
Inner half . 14 14 . 12 . 14 9 . 14 . 7 14 . 5 . 13 3
Outer half 39 . 39 31 . 39 . 25 . 39 . 19 . 37 9 33 . 5 Central . 8 . 8 . 8 8 . 6 . 8 . 4 . 6 . 0 . 6 0
Other 16 16 . 12 16 . 8 . 16 . 7 . 15 5 12 0
Total. .77 .77 .63 .77 .48 .77 .37 .72 .19 .64. 8
Tumour pathology
The relationship between the grade of malignancy and prognosis in breast
carcinoma was demonstrated by Greenough in 1925 and confirmed by Scarff
(Patey and Scarf, 1928) and Bloom (1950) and Bloom and Richardson (1957).
The effect ofhost factors has been studied by many workers (McCarty and Mahle,
1921; Black, 1965; Black and Asire, 1969; Black and Speer, 1958, 1960; Black,
Kerpe and Speer, 1953; Black, Opler, and Speer, 1954, 1956 and Hamlin, 1968)
and in this study the pathology ofthe tumours was assessed for both these factors
using the criteria laid down by Greenough (1925), Patey and Scarff (1928) and
Bloom (1950) for the malignancy grading and the method outlined by Hamlin
(1968) for the assessment of host factors.
Where slides or blocks were available for study, an assessment of malignancy
grading (Bloom, 1950) was made in all cases which had not recieved pre-operative
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irradiation. A complete assessment of host factors (Hamlin, 1968) could be
made onlyin cases treated byradical mastectomy. Fortotal (simple) mastectomy
specimens and partial mastectomy specimens a measure of host defence reaction
was attempted by assessing the cellular infiltration in and around the tumour.
Thus the malignancy grading is given as Grade I, II or III in ascending degrees
of malignancy. Host defence reaction (H.D.R.) in radical specimens is given as
D-, D+ and D++ in ascending degrees of evidence of host reaction; in
total (simple) mastectomy specimens and biopsy specimens the measure of host
reaction is given as d-, d+ and d++.
Malignancy grading
Table XIV gives the malignancy grading correlated with survival in 68 cases
treated primarily by radical mastectomy (one intraduct and one colloid being
excluded, as this method of grading is inapplicable to these types of breast
carcinoma).
TABLE XIV.-Survival at Follow-up of 68 Cases in Malignancy Grades
I, II, and III
Malignancy grades
No. of cases I II III
Total . . . 5 45 18
Alive at F.U. at 1 year . . 5 39 16
Alive at F.U. at 2 years . . 4 36 11
Alive at F.U. at 3 years . . 4 26 6
Alive at F.U. at 5 years . 4 13 (+6)* 3 (+2)*
Alive at F.U. at 10 years . 2 6 (+6)t 0 (+3)t
* Cases still alive at follow-up but not followed 5 years.
t Cases still alive at follow-up but not followed 10 years.
The general trend seen here is similar to that found by Bloom (1950) and
Bloom and Richardson (1957) and when divided by staging it is clear that the
grade of malignancy is closely related to the stage of the disease when first
seen, as is the degree of node involvement (Table XV).
TABLE XV.-Clinical Staging of 68 Cases in Malignancy Grades I,
II, and III
Stage
Early Moderate Late
Total No. of cases . . 11 30 27
No. of cases in Grade I . 2 2 1
No. of cases in Grade II . 6 21 18
No. of cases in Grade III . 3 7 8
The proportion of cases in Grades II and III is higher in this series of cases
under 35 than in Bloom's (1950) series which, of course, includes all ages.
Host Defence Reaction (H.D.R.) grading
The correlation between H.D.R. and survival in the patients treated by
radical mastectomy is given in the histograms (Fig. 1) and it can be seen that
not only do a higher proportion of the cases with a D++ score survive 5 years
but the gradient of the fall due to death in the first 3 years is much steeper in
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FIG. 1. Survival of 69 cases treated initially by radical mastectomy subdivided by H.D.R.
grading.
those cases with a D- score than those with a D+ and D++ score. These
findings agree with those of Hamlin (1968) but again as with the malignancy
grading, the proportion of cases in this present series in the poor prognosis D
group, is larger than in Hamlin's (1968) series which included all ages.
When divided by staging of the disease the relationship of H.D.R. to clinical
stage is shown (Table XVI).
TABLE XVI. Clinical Staging Related to H.D.R.
Stage No. D- D+ D+ +
Early. 11 4 . 3 . 4
Moderate 30 10 . 15 5
Late 28 18 9 . 1
69 32 . 27 10
N.B. Excluding one intraduct in early cases.
Combined malignancy and H.D.R. gradings
The 68 radical mastectomy cases in which these gradings are applicable are
divided into 5 categories:
(1) M++D : 28 cases M+ + corresponding to malignancy
(2) M++D[+: 25 cases grades II and II (2) M+±D+: 25 casesM+correponding to malignancy
(3) M++D++: 10 cases gradeI
(4) M+ID-: 4 cases M+ = well differentiatedl M± + = moderately differentiated
(5) M+ID+: I case and undlifferentiated/653 ANALYSIS OF 101 CASES OF CARCINOMA OF BREAST
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FIG. 2. (a) Survival ofMA+ +D- cases treated initially by radical mastectomy. (b) Survival
of M+ +D+ cases treated initially by radical mastectomy. (c) Survival of M+ +D+ +
cases treated initially by radical mastectomy.
Survivals for Groups (1), (2) and (3) are shown in three histograms (Fig.
2a, b, and c). Survivals for Groups (4) and (5) are given below:
(4) M+D-:
(5) M+D+:
One died within 2 years at 13 months.
One alive at 5 years 4 months.
One alive at 13 years 7 months.
One dead at 11 years 4 months.
One alive 6 years.
Table XVII shows distribution of 68 cases in M and ID grades in three clinical
stages.
TABLE XVIJ.-Clinical Staging Related to H and D Grading
Clinical stage No. M+ +D- Ml+ +D+ M+TD+ + M+D-
Early . 11 3 2 . 4 . 1
Intermediate . 30 . 8 . 15 . 5 . 2
Late 27 17 . 8 1 . 1
M+D+
1
0
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Host defence reaction grades of cases treated by mastectomy (not radical)
Eight cases were treated by total mastectomy as the initial form of treatment
(for definition of terms see below). Two cases were intraduct and therefore not
given a " d " score. Of the other cases, 3 gave a d- score and none survived
5 years. The other 3 cases gave a d++ score; 1 died at 2 years 5 months, the
other 2 were alive at 9 years and 5 years 11 months.
In 13 cases partial mastectomy was performed before radiotherapy. Six
cases gave a d- score, all were dead at follow-up, 2 having survived 5 years,
dying at 7 years 7 months and 14 years 8 months. Six gave a d+ score; all
were dead at follow-up, 2 having survived 5 years 2 months, and 9 years 7 months.
One case gave a d++ score and died 7 months after radiotherapy.
Axillary nodal metastases
The poorer prognosis which is known to accompany nodal metastases, high
grade malignancy and poor host reaction, is again seen in this series. Tables
XVIII, XIX and XX give details of survival related to malignancy grading,
H.D.R. and nodal metastases.
TABLE XVIII.-Survival Related to Nodal Metastases in Cases Treated by
Radical Mastectomy
No. of No. followed No. surviving No. followed No. surviving
cases 5 years 5 years 10 years 10 years
Nodes-ve . 16 . 13 13 . 6 6
Nodes +ve . 54 . 48 . 9 . 44 . 4
Total No. 70 61 . 22 50 . 10
Treatment and survival
Initial treatment varied because many cases were referred by other centres.
The cases may however be divided into three categories: radiotherapy, total
mastectomy, and radical mastectomy.
Radiotherapy
Of the 23 cases in this group, 13 had partial mastectomy before radiotherapy.
Partial mastectomy refers to removal of breast lump and surrounding breast
tissue. Fifteen cases received surgery after radiotherapy and this was total
(3 cases) or radical (11 cases) mastectomy or axillary block dissection (1 case).
Of the 8 cases not receiving subsequent surgery, 2 survived 5 years (both
intermediate stage cases). Two of the 3 cases receiving subsequent total
mastectomy survived 5 years, one of these dying at 14 years 8 months. Of the
11 cases who had subsequent radical mastectomy, 1 was still alive at 3 years and
2 survived 5 years, 1 of these dying at 10 years 4 months. The one case which
had a post radiotherapy axillary dissection died at 7 years and 7 months. Follow-
up and survival of radiotherapy cases are depicted in Table XXI. No early
stage patient received radiotherapy as the initial treatment.
Total mastectomy
Total mastectomy refers to the removal of the breast including its axillary
tail, but not the removal of axillary nodes. Of the 8 cases in this group, all
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Staj
Interm
Late
Total
TABLE XXI.-Radiotherapy Cases: Follow-up and Survival Figures at
1, 2, 3, 5, and 10 Years
No. No. No. No. No. No. No. No. No.
fol- sur- fol- sur- fol- sur- fol- sur- fol-
No. of lowed viving lowed viving lowed viving lowed viving lowed
ge cases 1 yr 1 yr 2 yr 2 yr 3 yr 3 yr 5yr 5 yr 10 yr
,ediate 12 . 12 . 11 . 12 . 8 . 12 . 8 . 12 . 6 . 12 .
. 11 . 11 . 8 .11 . 4 . 11 . 4 . 10 . 7 . 10 .
. 23 . 23 . 19 .23 . 12 . 23 . 12 . 22 . 7 . 22 .
No.
sur-
viving
lOyr
1
1
2
received post-operative radiotherapy except the 2 intraduct tumours in the
early stage, both of which survived 10 years. Two of the 6 cases which had
radiotherapy survived 5 years and both ofthese were in the early stage. Results
are shown in Table XXII.
TABLE XXII.-Total Mastectomy Cases: Follow-up and Survival Figures at
1, 2, 3, 5, and 10 Years
Stage
Early
Intermediate
Late
Total
No.
fol-
No. of lowed
cases -1 yr
5 . 5
1 . 1
2 .2
8 .8
No.
sur-
viving
1 yr
.5.
.1.
. 0.
.6.
No.
fol-
lowed
2yr
5
1
2
8
No.
sur-
viving
2 yr
5
1
0
6
No.
fol-
lowed
3 yr
5
1
2
8
No.
sur-
viving
3 yr
4
0
0
4
No.
fol-
lowed
5 yr
5 .
1.
2.
8.
No.
sur-
viving
5 yr
5.
0.
0.
5 .
No.
fol-
lowed
lOyr
3.
1.
2.
6.
No.
sur-
viving
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Radical mastectomy
This refers to removal of the breast with pectorales major and minor, and the
axillary nodes. Seventy cases fall into this group and their distribution in
clinical stages and survival are given in Table XXIII.
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Tot
TABLE XXIII.-Radical mastectomy Cases: Follow-up and Survival Figures
at 1, 2, 3, 5, and 10 years
No. No. No. No. No. No. No. No. No. N
fol- sur- fol- sur- fol- sur- fol- sur- fol- Su
No. of lowed viving lowed viving lowed viving lowed viving lowed viv Stage cases 1 yr 1 yr 2 yr 2 yr 3 yr 3 yr 5 yr 5 yr 10 yr 10
ly . . 12 . 12 . 11 . 12 . 11 . 11 . 9 . 9 . 7 . 6
rinediate 30 . 30 . 30 . 30 . 27 . 30 . 20 . 26 . 9 . 21
e. .28 .28 .21 .28. 15 .28. 9 .27. 6 .24.
al. .70 .70 .62 .70 .53 .69 .38 .62 .22 .51. 1
o.
Ir-
ving
Iyr
4
4
2
L0
Early stage
In the early stage 3 cases had radical mastectomy only (1 an intraduct tumour)
and all 3 are alive at 8 years and 15 years (2 cases) later.
Nine cases received radiotherapy which was post-operative in all but 1 case
in which there was a delay of 5 months. Three cases were alive at follow-up
ofless than 5 years; 4 cases, all alive, survived 5 years and 2 ofthese have survived
10 years.
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Intermediate stage
Four cases underwent radical mastectomy only. Three of these are alive
and have survived 5 years, 2 of which survived 10 years.
Twenty-six cases received radiotherapy which was post-operative in all but
1 case in which there was an interval of 2 years 4 months. Six cases survived
5 years, 1 of which died at 11 years 4 months; the other 5 are alive at periods
from 5 years 4 months to 10 years 8 months.
Late stage
Two cases underwent radical mastectomy only; both are alive at 7 years
7 months and 10 years 2 months.
Twenty-six cases underwent radical mastectomy and radiotherapy. One
case, not followed for 5 years is alive at 3 years 2 months. Four survived 5 years;
1 of these died at 9 years 5 months, and 3 are alive 6 years 1 month, 6 years
5 months and 13 years.
Treatment related to pathology and survival
Because pre-operative irradiation alters the histological appearance of both
the tumour and the host reaction, cases which received irradiation before
mastectomy (partial, total or radical) could not be assessed for malignancy grade
or host defence reaction and are therefore excluded from this section. A few
cases, viz. 3 intraduct carcinomata and 2 " colloid " tumours, i.e. types which
cannot be given a malignancy grading are also excluded. The 3 intraduct
carcinomata were all in the early stage. One of these patienits was treated by
TABLE XXV
Malignancy grade
Early 8tage
Grade I -no cases
Grade II-no cases
Grade II
3 cases
Intermediate 8tage
Grade I
1 case
Grade II
6 cases
Grade III
2 cases
Late 8tage
Grade I No cases
Grade II . d-
5 cases
d+
*d++
Grade III . d-
1 case
" d "
Grade HVT+
d- . 1dead 2 yr 10 mth
d++ . 1alive 9 yr
1 alive 5 yr 11 mth
d+ . 1dead 9 yr 7 mth
d- . 1dead 14 yr 8 mth
1 dead 7 yr 7 mth
1 dead 4 yr 10 mth
I dead 3 yr 3 mth
I dead I yr 3 mth
d+ . No cases
d+ + I 1 dead 2 yr 5 mth
d- . No cases
d+ . 1dead I yr 3 mth
d++ . 1dead 7 mth
1 dead 1 yr 10 mth
1 dead 1 yr 4 mth
No cases
3 dead between 3 mth and 4 yr
1 dead at 7 yr
HVT-
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radical mastectomy (alive without signs of recurrence 15 years later) and the
other 2 were treated by local mastectomy (both alive with no signs of recurrence
at 10 and 16 years). One patient with a colloid tumour (H.D.R. grade D+) had
uninvolved nodes and was alive 13 years after radical mastectomy and post-
operative radiotherapy. The other patient with a colloid tumour (H.D.R. grade
D+) and uninvolved nodes died 5 years 2 months following partial mastectomy
and radiotherapy.
Eighty-six cases consisting of 12 partial mastectomy cases, 6 total mastectomy
cases and 68 radical mastectomy cases, none of which received pre-operative
radiotherapy, are grouped according to malignancy grading (Bloom, 1950) and
subdivided according to clinical staging and host defence reaction, H.D.R.
(Hamlin, 1968) and treatment, in Tables XXIV and XXV.
DISCUSSION
McWhirter (1957) states that 10% of breast carcinomata occur under 40 years
of age. He calculated that there were approximately 340 new cases of breast
carcinoma per million population per year, and assuming that each general
practitioner has 2000 patients, and that there are 500 general practitioners per
million population, then each general practitioner would see one carcinoma of
the breast under 40 years of age every 15 years, approximately twice during his
working life. The disease is uncommon under 30 years (de Cholnoky, 1943) and
is rare in youth and childhood (Bogen, 1935; McDivitt and Stewart, 1966).
Age.-Certain authors (Nathanson and Welch, 1936; Ewing, 1940; Geschickter,
1945; Nohrman, 1949) believe the prognosis to be worse in the under 35 year old
group. Certainly the results of this series appear to confirm this. Others (de
Cholnoky, 1943; Truscott, 1947; Cade, 1948; MacDonald and Wilcox, 1956;
Treves and Holleb, 1958; White, 1960; Watson, 1966) do not think that the
prognosis is necessarily worse.
Treves and Holleb (1958) found it impossible to predict results of treatment
for any specific age below 35 years on the basis ofage alone. Their 5 year clinical
cure rates for the age groups, under 26 years, 26 to 30 years, 31 to 34 years were
respectively 210%, 43 80% and 40.20%. In this series for similar age groups the
5 year survival figures are 25%, 27% and 41% respectively. It is noteworthy
that of 9 cases under 26 years, 2 survived 10 years, both being alive at follow-up.
One of these cases had a total mastectomy at the age 24 years for a lump which
had been present and increasing in size for 1 year. The lump was an intraduct
carcinoma and she was alive 16 years later. The other patient noticed a lump
in her breast following trauma when she was 20 years old. Three years later
when 3 months pregnant, the lump increased in size and 2 years later when she
was 25, a radical mastectomy was carried out. The tumour was of Grade I
malignancy, H.D.R. D and axillary nodes were involved histologically but not
detected clinically. Post-operative radiotherapy was given and 5 years later
oophorectomy carried out and durabolin given for an axillary recurrence. Eight
years later (that is 13 years 7 months after radical mastectomy) there were no
signs of recurrence.
Family history. In this series 17 cases gave a family history of breast cancer.
In Treves and Holleb's (1958) series about 10% of those under 35 had a family
history of breast cancer. Following the pioneer work of Slye (1933) the signifi-
cance of a family history has been confirmed by many authors (Penrose et al.,
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1948; Smithers, 1948; Smithers et al., 1952; Treves and Holleb, 1958). " Breast
cancer families" have been reported by Wood and Darling (1943), Smithers
et al. (1952), Oliver (1958) and Stephens et al. (1958). Passey (1949) found no
evidence of hereditary predisposition to breast cancer whereas Jacobson (1946)
found evidence of predisposition to cancer generally but not to breast cancer
specifically. On the other hand Penrose et al. (1948) and Smithers (1948) found
a specific hereditary tendency to breast cancer, but not to cancer generally.
Jacobson (1946) observed that breast cancer appeared at an earlier age in patients
with a familial predisposition to the disease and Morse (1951) noted that the
disease appeared 10 years earlier in daughters whose mothers had the disease.
Smithers (1948), though agreeing that a family history is a predisposing factor,
found no evidence to suggest that the tumours appear at an earlier age in successive
generations.
Three of the cases in this series had been treated by radical at an age at least
20 years younger than when their mothers required similar treatment. In a
study of twins one of whom presented with cancer, a greater incidence of cancer
has been found in the series of second twins if the twins are monozygotic as
opposed to dizygotic (Busk et at., 1948; Smithers et al., 1952). Twins have also
been observed to develop breast cancer at similar times, in the same breast and
at the identical site in that breast (McFarland and Meade, 1932; Munford and
Linder, 1936).
Marital status. Seventy-nine cases (78%) were married and 22 cases (22%)
were single, a ratio of approximately 3X6: 1. In Treves and Holleb's (1958)
series, 82% were married and 18% single, a ratio of approximately 4 5: 1.
In the present series 5 and 10 year survivals of the single group were 4000 and
22% compared with similar survival times in the married group of 34% and 15%
respectively.
Generally the incidence of breast cancer is higher in single than in married
women (Smithers et al., 1952; Haagensen, 1956). This is certainly true in the
over 40 age-group (Lane-Claypon, 1926; Harnett, 1948; Smithers et al., 1952).
Lilienfeld (1956) also noted this increased incidence in single women from 35
to 40 years, but found that under 35 years the rates of single and marriedwomen
were the same.
Parity. Treves and Holleb (1958) noted that 66% of their cases under 35
years had been pregnant at least once. In this series 57 cases in whom an
obstetric history was recorded had been pregnant at least once, although 4 of
these did not go to term. The 5 and 10 year survival figures of the nulliparous
group were 35%0 and 20% respectively whilst survival figures for similar periods
in the parous group were 310% and 120%. Within the parous group the 5 year
survival figures of those who had borne 1, 2, 3 or more children were 27%, 22%
and 5500 respectively and the 10 year survival figures were 11%, 12% and 14%
respectively.
There appears to be less risk of breast cancer developing in women who have
borne children (Lane-Claypon, 1926; Bogen, 1935; Clemmesen, 1951; Cappellini
et al., 1.957; Cutler, 1961). Some figures have shown that the risk decreases
with the increasing number of children borne and the incidence in women with
4 or more children is about halfthat ofnulliparous women (Peller, 1940; MacMahon
et al., 1968). Recently however, MacMahon (1969) in an international survey
has noted that women who have their first child tinder the age of 20 have only
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about one-third of the breast cancer risk of those whose first birth is delayed
until they are 35 years old, and women whose first birth occurs over the age of
35 have higher breast cancer rates than non-parous women. MacMahon (1969)
observed that the protective effect ofpregnancy disappears at some point between
25 and 35years ofage andthat duringpregnancy whilstthe output ofalloestrogens
increases, that of oestriol (non-carcinogenic) increases to a much greater extent
than oestrone and oestradiol (carcinogenic fractions). Unfortunately in the
present series under study, the ages at which first births occurred were not
recorded. Survival rates generally do not differ in nulliparous and parous
patients (MacKay and Sellers, 1965; MacMahon et al., 1968) but in this series, the
nulliparous women tended to have better 5 and 10 year survival rates. Within
the parous group survival does not appear to be related to the number of children
born (Peller, 1940; MacMahon et al., 1968). In this series however, 55% of
those who had borne 3 or more children survived 5 years.
Breastfeeding.-Thirty-nine cases (73%) within the parous group had breast
fed at least once. Cutler (1961) observed the general opinion that there is an
increased incidence of breast cancer in those women who have not borne children
or who have not breast fed. The apparent protective effect of parity and breast
feeding is noted by Lane-Claypon (1926), Clemmesen (1951), Rennaes and Holan
(1953). Lane-Claypon (1926) also suggested that there is an added protection
derived from longer duration of breast feeding. The results of an international
survey show conclusively that breast feeding is not protective against breast
cancer even in areas of the world where prolonged lactation is customary (Mac-
Mahon, 1969). In the present series the 5 year survival figure of the group that
did not breast feed was 62% and that of the group that did breast feed was
27%.
Pregnancy and lactation.-Seventy per cent of breast carcinomas which occur
in association with pregnancy are found in women under the age of 30 (Kilgore
and Bloodgood, 1929). The incidence of association of breast cancer with
pregnancy has been recorded to be between 1% (Robinson, 1965) and 3% (White,
1955).
The obstetrician, however, rarely sees breast cancer complicating pregnancy,
the incidence recorded being from 1 in 10,000 pregnancies (Robinson, 1965) to
3 in 10,000 pregnancies (White, 1955) and from 8 in 32,000 deliveries (Nelson,
1956) to 4 in 45,000 deliveries (Power, 1942). Despite this, it is essential that
the breasts are examined at regular intervals. Factors which may influence
prognosis are:
(1) The breasts are increased in size and a lump is therefore noticed only
when large. Fibroadenomata remain easily palpable and mobile but carciloma,
like fibroadenosis, tends to melt into the general breast tissue becoming less
significant. Treves and Holleb (1958) found the delay period in the pregnant
twice that in the non-pregnant.
(2) The rate oftumour growth may be increased due to high levels ofoestrogen
(MacMahon, 1969).
(3) Both involvement of regional lymphatic and blood stream dissemination
may be increased by the extreme vascularity of the breast in pregnancy.
(4) Tumours occurring during pregnancy are often of high grade malignancy
(Bloom, 1955).
Cade (1964) in his assessment, takes into account the effect of the pregnancy
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on the breast cancer, the effect of the cancer on the pregnancy, the effect of
treatment on the cancer and foetus and also the management of the patient
with regard to future pregnancies. Cade observed that in the non-pregnant
55% of breast cancers are hormone independent whereas in pregnancy only
10% are hormone independent (Cade, 1964) and provided treatment is adequate,
pregnancy has little effect on the course of the lesion. Cade (1964) also noticed
regression of breast cancer in cases of spontaneous abortion and he advised
termination of pregnancy up to 5 months; if discovered later in pregnancy, he
advised Caesarian section or normal delivery. Treves and Holleb (1958) found
improved results with termination, as did Cheek (1953) in the first two trimesters.
White and White (1956) did not think termination improved results and Adair
(1949) advised termination only if axillary nodes were involved.
Recently Peters (1968) outlined her management of breast cancer in pregnancy
and lactation:
(1) In the first half of pregnancy the lesion is treated in the conventional
manner but no radiotherapy is given and abortion is not advised.
(2) In the latter half of pregnancy, greater caution is advised; if the growth
is early or appears less aggressive, the patient is observed and treatment carried
out in the early post-partum period and lactation is terminated with oestrogens.
With advanced lesions the growth is treated and the pregnancy terminated.
(3) In lactation: this is first suppressed and the breast lesion then treated.
(4) Of subsequent pregnancy, Peters (1968) thinks that the benefits gained
outweigh the doubtful benefit of prophylactic castration in the young. Under
35 years she encourages pregnancy after a one year interval following treatment,
but over 35 years of age prophylactic castration may be advised when clinically
indicated.
Cade (1964) advised against further pregnancies or if this was felt to be too
harsh, a delay ofat least 5 years before further pregnancy was advised. Harring-
ton (1937) only allowed further pregnancies if the lesion were early and there
were no involved nodes but advised a delay of 3 to 5 years. Haagensen and
Stout (1943) allowed further pregnancies provided there were no signs of recur-
rence lest cancer cells may be stimulated by the pregnancy. However, as one
million cells can be accommodated in a cubic millimetre, their presence may well
be overlooked. White and White (1956) thought that the problem would resolve
by natural selection as only those who are fit enough will survive long enough to
produce offspring. This again is questionable, as in this series 2 pregnancies
were initiated whilst post-radical mastectomy irradiation was being given.
Delay.-Sixty per cent of those cases with a delay period of under 1 month
had histologically involved axillary nodes compared with 76% of those with a
delay period of 3 to 7 months. Five year survival figures were 44% and 26%
respectively. Ninety per cent of cases with delay periods of 1 year or more
had histologically involved nodes and the 5 year survival figure was 22%.
Nohrman (1949) found that the delay period in younger patients was less
than for other ages and 50% of his series of under 35 year old patients presented
within 3 months. In the present series, 58% presented within 3 months. With
a delay period over 3 months Smithers et al. (1952) found a significant drop in
survival and concluded that the duration of a tumour is more significant with
rapidly growing lesions and that slowly-growing tumours may have a good
prognosis even after 1 year. Treves and Holleb (1958) (under 35 year series)
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found that cases with a delay period of under 6 months had an axillary node
involvement rate of 58*3% with a 42*5% 5 year survival compared with a delay
ofover 6 months in which 64% had involved axillary nodes and the 5 year survival
was 33.8%. Bloom (1965) found that in a series of breast carcinomata from
all age groups 64% presented within 6 months and he thought that survival was
largely related to the histological type of growth. Eberbach (1949) suggested
that the rate ofgrowth of the tumour is the deciding factor, and as Kraus (1953)
also observed, presentation is earlier with the more malignant tumours than
with the less malignant ones which grow more slowly, have a longer delay period,
and a better prognosis. White (1960) found that with a delay over 6 months,
there was a greater incidence of involved nodes although many cases did well;
presumably in these cases relatively slow growth was accompanied by good host
reaction.
Strax et al. (1969) have shown that with earlier diagnosis, more patients will
be treated in the early stage, and there should therefore be improved results.
They found that repeated screening by both clinical examination and mammo-
graphy resulted in a greater number of carcinomata being detected than by
either method alone. In the control group (i.e. those not subjected to screening)
56% ofpatients with breast carcinoma had evidence ofaxillary node involvement
compared with 35% ofthose patients found to have carcinoma on initial screening
and 19% ofthose diagnosed on subsequent screenings.
McSwain and Coles (1947) and Berkson et al. (1957) found that over the
years there had been an increase in the number of patients with uninvolved
nodes with a corresponding improvement in survival.
Park and Lees (1951) and McKinnon (1954) suggested that earlier diagnosis
does not improve the results of surgical treatment and imply that no treatment
of the disease by any method prolongs the patient's life.
Clinical presentation.-Treves and Holleb (1958) observed that only 1% of
their cases was discovered in a routine medical examination. In this series no
case was so discovered.
It has been suggested that when a breast cancer becomes clinically apparent
it is in the final quarter ofits life (Collins et al., 1956). Strax et al. (1969) however,
have shown that less malignant and less extensive lesions with more favourable
prognoses have been detected by screening methods with consequent reduction
of the delay period.
Regular self-examination or attendance at a special breast clinic may help
towards early diagnosis.
Clinical stage.-The clinical stage is an assessment ofthe extent ofthe disease.
There have been many methods of staging and at present the T.N.M. system is
internationally recognized. Difficulties and inaccuracies arise from varying
methods of tumour measurement (see below) and assessment of regional lymph
nodes and detection of metastases. In this series cases were classified on a
T.N.M. basis. Although the staging was approximate, the prognosis, as in all
series, is closely related to the clinical stage with a relatively high 3 and 5 year
survival of cases in the early stage (81% and 78% respectively) and a poorer
survival in the intermediate and late stages (intermediate 65% and 38%, late
32% and 18% respectively). Similarly within each stage the proportion of
cases surviving 10 years is much greater in the early stage (67%) than the propor-
tion of cases surviving 10 years in the intermediate (14%) and late stage (8%).
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Size.-Approximately halfthe tumours were 2-5 cm. in their greatest diameter.
A correlation between tumour size and prognosis is found in this series; the smaller
the tumour, the better the prognosis. This confirms results of Harrington
(1946), Rennaes (1960), and Robbins (1962). Treves and Holleb (1958) thought
that size alone was of prognostic significance regardless of axillary node involve-
ment and that the 5 year clinical cure rate diminished as tumour size increased.
White (1960) noted that with tumours less than 5 cm., the smaller the size the
better the prognosis. Further analysis of the cases studied by Hamlin (1968)
has shown a correlation between size and prognosis (as yet unpublished). How-
ever as Cutler (1961) observed, some small primary tumours produce massive
secondaries and size alone is not always an index of curability.
Site.-Distribution of cases in the various sites in this series is similar to that
seen in all ages but survival appears approximately equal for all sites. Treves
and Holleb (1958) found the tumour site to have little or no influence on the
clinical cure rate.
Most authors, however, working with cases of all ages, found a worse prognosis
with inner quadrant tumours especially in early stage growths (Haagensen and
Stout, 1943; Truscott, 1947; Nohrman, 1949; Handley, 1951; Urban, 1959).
Conversely in 1951 Haagensen and Stout published a series in which patients
with tumours in the inner quadrants had the better prognosis.
Pathology.-In the series of 273 cases from all age groups published by Hamlin
in 1968, several points relating to the pathology of the tumours were noted:
(1) Well differentiated carcinomas ofGrade I malignancy had a good prognosis
with a 50% 15 year survival both in the presence and absence of host reaction.
(2) The prognosis of cases with tumours of malignancy Grades II and III
was closely related to the presence or absence of nodal metastases and to the
host defence reaction. It was also noted that these two factors were related to
each other.
(3) There was a higher incidence of the histological types of tumours which
have a relatively poor prognosis in patients who developed breast carcinoma
during the reproductive years of life, i.e. before the age of 45, and the prognosis
associated with any one histological group is less good in this age group than in
the age group in the premenopausal years, i.e. 45 to 55 years.
The analyses in this series show the same general trend. Of the group of
cases with malignancy Grade I tumours, only one case which was in the late
clinical stage, died under 5 years. The long survival of the other cases (all still
alive) is unrelated to the H.D.R.
In only 16 (23%) of the 70 patients treated by radical mastectomy were the
axillary nodes found histologically free of metastases. All these cases are alive
at follow-up at from 2 years to 16 years after radical mastectomy.
Of 63 cases with malignancy Grades II and III tumours, 12 had uninvolved
lymph nodes; in all but 4 cases the absence ofaxillary metastases was accompanied
by some evidence of host reaction and all but 2 cases are alive at follow-up.
Long-term survival of cases with these more malignant tumours, with or without
invaded lymph nodes, was certainly more frequent among those cases in which
a host reaction was present (Fig. 2).
Long-term survival in the Hamlin (1968) series was found to be associated
with tumours of Grade I malignancy, and with tumours of Grades II and III
malignancy, which were accompanied by a measurable degree of host reaction.
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The proportion of cases in the present series with Grade I malignancy tumours,
5 out of 101, is much less than in the Bloom and Richardson series published
in 1957 (362 out of 1,409) and in Hamlin's series (1968) (61 out of 273). Both
ofthese earlier series were drawn from cases of all age groups.
The proportion of cases with tumours of malignancy Grades II and III in
the three D grades in the Hamlin series was D-, 32.2%; D+, 41.6%; and
D++, 25*5%. In the present series, the proportion of cases in the poorer
prognosis group giving a D- score is much greater, viz. D- 41%, D+ 37%
and D+-+ 15%.
Because a high proportion of the cases in the breast series have not yet been
followed up for 10 years, it is not possible to compare the prognosis in each ofthe
separate M and D groups with those in the larger series analysed by this method
(Hamlin, 1968), but it is clear that a higher proportion of cases in this young
age group series have tumours with histological appearances that have been
found to be associated with a poor prognosis (Hamlin, 1968).
Treatment and survival.-Probably no subject arouses as much controversy
as the treatment of carcinoma of the breast. A recent survey of the Fellows of
the Association of Surgeons of Great Britain and Ireland revealed the diversity
ofopinions on methods of treatment for a particular stage of the disease (British
JournalofSurgery, 1969). In this country, controlled clinical trials are at present
being conducted to assess the value of various treatments. Despite advances,
the death rate over the last 30 years has remained static (Adams and Spicer,
1965; Cutler, 1966). In most series for all ages the 5 year survival figure is
50% and the 10 year 30% (Forrest, 1969). In this series of under 35 year old
patients, 5 and 10 year survival figures are 36% and 18% respectively.
Most would agree that total or radical mastectomy with or without radio-
therapy are the main forms oftreatment for cases in Stages I and II (corresponding
with early and intermediate stages in this series), but that for cases in Stages III
and IVradiotherapy is to bepreferred. In this series radiotherapyas the primary
treatment was given only to intermediate (12) and late (11) stage cases. Under-
standably the 5 year survival figure ofthis group (32%) was less than that ofthe
8 cases treated primarily by total mastectomy (50%) for in this latter group 5
cases were in the early stage, 2 being intraduct tumour cases. A very large
proportion of the 70 cases for whom radical mastectomy was the primary treat-
ment received subsequent radiotherapy. Of the 61 cases (87%) which did
receive subsequent radiotherapy, 14 cases survived 5 years, these being alive at
follow-up from 5 years 4 months to 13 years 7 months except for 2 cases that
died at 9 years 5 months and 11 years 4 months. Thirteen per cent of the cases
treated primarily by radical mastectomy did not receive subsequent radiotherapy;
of these only 1 died under 5 years, the other 8 are all alive at follow-up from
5-16 years after radical mastectomy. All but 1 ofthese cases had negative nodes
and all but 1 other case showed an H.D.R. of D+ or D++. A number of
authorities have questioned the value of post-operative radiotherapy (Hall and
Bagby, 1938; de Cholnoky, 1943; Treves and Holleb, 1958). Easson (1968)
reported identical survival of Stages I and II radical mastectomy cases with
and without post-operative irradiation. Bond (1967) thinks irradiation is
contra-indicated in those cases in which the nodes are negative. A number of
treatment trials for breast carcinoma are now in progress and when these are
complete it may be possible to assess the value of post-operative irradiation in
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the treatment of breast carcinoma. It is important, however, in such trials to
have detailed assessment of all factors which have been shown to have some
influence on prognosis so that a clear picture may be gained of the effect which
different forms of treatment are having.
Three points with regard to clinical evaluation require elaboration:
(1) The clinical assessment of node involvement is notoriously inaccurate.
(2) The measurement of tumour size by callipers may be misleading. A
"scirrhous " tumour surrounded by adenosis may measure 6 cm. T3 in clinical
examination, but when excised is found to contain a 2 cm. tumour TI.
Thus on clinical grounds this would be assigned to an advanced stage (III)
and treated by radiotherapy rather than surgery.
(3) The T.N.M. staging sizes especially Ti < 2 cm. to T2 5 cm. represents
too great a difference because the prognosis for a 2 5 cm. T2 is quite different
from a 5 cm. tumour T2.
In all but the most advanced cases when a drill or a needle biopsy only is
necessary to confirm the clinical diagnosis, the lump must be removed for frozen
section examination.
Under anaesthesia a more accurate evaluation oftumour size and node involve-
ment may be made and the breast lump excised with an adequate margin of
normal tissue measured and submitted to frozen section (for immediate diagnosis)
and paraffin section (for tumour characterization). It is suggested that the
treatment plan should at this stage be based on the size of the tumour, the
malignancy grading and the presence and degree of host reaction.
CONCLUSIONS
In this series prognosis appears to be related to the delay period, clinical
stage, size of tumour, the histological appearances of the tumour, and presence
or absence of axillary metastases.
In the histological appearances of the tumour, both the grade of malignancy
of the tumour and the host reaction to it appear to be related to prognosis.
In comparison with groups of patients drawn from all age groups, a smaller
proportion of patients in this age group have tumours of malignancy Grade I
and of those with tumours of malignancy Grades II and III a smaller proportion
exhibit a good host reaction.
We are grateful to the many pathologists of referring hospitals for their
co-operation in supplying histological material, and to the surgeons and radio-
therapists of the Royal Marsden Hospital and referring hospitals for allowing us
to study cases admitted under their care.
We wish to thank Mr. C. H. Chadwin and Miss D. Bower for technical
assistance, Miss L. Pegus for the illustrations and Miss M. Craddock for secretarial
assistance.
REFERENCES
ADAIM, F. E.-(1949) Ann. R. Coll. Surg., 4, 360.
ADAMs, M. J. T. AND SPICER, C. C.-(1965) Lancet, ii, 732.
BERKSON, J., HIARRRGTON, S. W., CLAGIETT, 0. T., KIRKILIN, J. W., DOCKERTY, M. B.
AND MCDONALD, J. R.-(1957) StaffMeet. Mayo Clin., 32, 645.
BLACK, M. M.-(1965) Prog. din. Cancer, 1, 26.668 T. G. J. BRIGHTMORE, W. P. GREENING AND I. HAMLIN
BLACK, M. M. AND ASIRE, A.-(1969) Cancer, N.Y., 23, 251.
BLACK, M. M., KERPE, S. AND SPEER, F. D.-(1953) Am. J. Path. 29, 505.
BLACK, M. M., OPLER, S. R. AND SPEER, F. D.-(1954) Surgery, Gynec. Obstet., 98, 725.-
(1956) Surgery, Gynec. Obstet., 102, 599.
BLACK, M. M. AND SPEER, F. D.-(1958) Surgery Gynec. Obstet., 106, 163.-(1960)
Surgery Gynec. Obstet., 110, 477.
BLOOM, H. J. G.-(1950) Br. J. Cancer, 4, 259, 347.-(1955) Rep. Br. Emp. Cancer
Campn, 33, 30.-(1965) Br. J. Cancer, 19, 228.
BLOOM, H. J. G. AND RICHARDSON, W. W.-(1957) Br. J. Cancer, 11, 359.
BOGEN, R.-(1935) Am. J. publ. Hlth, 25, 245.
BOND, W. H.-(1967) reported in World Medicine, October 17, p. 68.
BRITISH JOURNAL OF SURGERY-(1969) Breast Cancer Symposium, 56, 782.
BUSK, T., CLEMMESEN, J. AND NIELSEN, A.-(1948) Br. J. Cancer, 2, 156.
CADE, S.-(1948) J. Am. med. Ass., 138, 1083.-(1964) J. Obstet. Gynaec. Br. Commonw.,
71, 341.
CAPELLINI, E., GUFFANTI, A. AND MONTINI, T.-(1957) Rass. ital. Chir. Med., 6, 1.
CHEEK, J. H.-(1953) Archs Surg., 66, 664.
CLEMMESEN, J.-(1951) Report on Oxford Symposium 1950. Acta Un. int. Cancr., 7, 24.
COLLINS, V. P., LOEFFLER, R. K. AND TIVEY, H.-(1956) Am. J. Roentg., 76, 988.
CUTLER, M.-(1961) 'Tumours of the Breast'. London (Pitman Medical Publishing
Co. Ltd.), pp. 152, 246.
CUTLER, S. J.-(1966) in 'Clinical Evaluation in Breast Cancer', edited by J. L. Hay-
ward and R. D. Bulbrook. New York (Academic Press), p. 215.
DARGENT, M. AND MAYER, M.-(1948) Presse m4d., 56, 561.
DE CHOLNOKY, T.-(1943) Surgery, G`ynec. Obstet., 77, 55.
EASSON, E. C.-(1968) in 'Factors Influencing Prognosis of Breast Cancer', edited by
A. P. M. Forrest and P. B. Kunkler. Edinburgh (Livingstone), p. 118.
EBERBACH, C. W.-(1949) Wis. med. J., 48, 132.
EWING, J.-(1940) 'Neoplastic Diseases; a Treatise on Tumours', 4th edition. Phila-
delphia (W. B. Saunders Co.).
FORREST, A. P. M.-(1969) in ' Recent Advances in Surgery', edited by Selwyn Taylor.
London (Churchill), p. 84.
GESCHICKTER, C. F.-(1945) 'Diseases of the Breast', 2nd edition. Philadelphia
(Lippincott), p. 404.
GREENOUGH, R. B.-(1925) J. Cancer Res., 9, 453.
GROSS, S. W. A.-(1880) 'A Practical Treatise on Tumours of the Mammary Gland;
Embracing their Histology, Pathology, Diagnosis, and Treatment'. New York
(D. Appleton & Co.), p. 146.
HAAGENSEN, C. D.-(1956) 'Diseases of the Breast'. Philadelphia (Saunders).
HAAGENSEN, C. D. AND STOUT, A. P.-(1943) Ann. Surg., 118, 859.-(1951) Ann. Surg.,
134, 151.
HALL, N. AND BAGBY, J. W.-(1938) J. Am. med. Ass., 110, 703.
HAMLIN, I.-(1968) Br. J. Cancer, 22, 383.
HANDLEY, R. S.-(1951) Proc. R. Soc. Med., 45, 565.
HARNETT, W. L.-(1948) Br. J. Cancer, 2, 212.
HARRINGTON, S. W.-(1937) Trans. Am. surg. Ass., 55, 209.-(1946) Surgery, St. Louis, 19, 154.
JACOBSON, O.-(1946) 'Heredity in Breast Cancer. A Genetic and Clinical Study of
200 Probands'. London (H. K. Lewis & Co., Ltd.).
KILGORE, A. R. AND BLOODGOOD, J. C.-(1929) Archs Surg., 18, 2079.
KRAUS, A. S.-(1953) Surgery, Gynec. Obstet., 96, 545.
LANE-CLAYPON, J. E.-(1926) Ministry ofHealth Reports on Public Health and Medical Subjects, No. 32. London (H.M. Stationery Office). LILIENFIELD, A. M.-(1956) Cancer, N.Y., 9, 927.ANALYSIS OF 101 CASES OF CARCINOMA OF BREAST 669
MCCARTY, W. C. AND MAHLE, A. E.-(1921) J. Lab. clin. Med., 6, 473.
MCDIVITT, R. W. AND STEWART, F. W.-(1966) J. Am. med. Ass., 195, 388.
MACDONALD, I. AND WILCOX, N. E.-(1956) Cancer, N.Y., 9, 281.
McFARLAND, J. AND MEADE, T. S.-(1932) Am. J. med. Sci., 184, 66.
MACKAY, E. N. AND SELLERS, A. H.-(1965) Can. med. Ass. J., 92, 647.
MCKINNON, N. E.-(1954) Lancet, i, 251.
MACMAHON, B., LIST, N. D. AND EISENBERG, H.-(1968) in 'Prognostic Factors in
Breast Cancer', edited by A. P. M. Forrest and P. B. Kunkler. Edinburgh
(Livingstone), p. 56.-(1969) Progress Report-International Collaborative Study
of Breast Cancer, p. 12.
MCSWAIN, B. AND COLES, J. H.-(1947) Cancer, N. Y., 10, 469.
MCWHIRTER, R.-(1957) J. Fac. Radiol., 8, 220.
MORSE, D. P.-(1951) Cancer, N.Y., 4, 745.
MUNFORD, S. E. AND LINDER, H.-(1936) Am. J. Cancer, 28, 393.
NATHANSON, I. T. AND WELCH, C. E.-(1936) Amt. J. Cancer, 28, 40.
NELSON, H. M.-(1956) Rocky Mount. med. J., 53, 287.
NOHRMAN, B. A.-(1949) Acta radiol., Suppl. 77, p. 1.
OLIVER, C. P.-(1958) Ann. N.Y. Acad. Sci., 71, 1198.
PARK, W. N. AND LEES, J. C.-(1951) Surgery Gynec. Obstet., 93, 129.
PASSEY, R. C.-(1949) Rep. Br. Emp. Cancer Campn, 27, 168.
PATEY, D. H. AND SCARFF, R. W.-(1928) Lancet, i, 801.
PELLER, S.-(1940) Surgery Gynec. Obstet., 71, 181.
PENROSE, L. S., MACKENZIE, H. J. AND KARN, M. N.-(1948) Br. J. Cancer, 2, 168.
PETERS, V.-(1968) in ' Prognostic Factors in Breast Cancer ', edited by A. P. M. Forrest
and P. B. KUNKLER. Edinburgh (Livingstone).
POWER, H. A.-(1942) Penn. med. J., 45, 1049.
RENNAES, S. AND HOLAN, L.-(1953) Nord. Med., 50, 967.
RENNAES, S.-(1960) Acta chir. scand., Suppl. 166.
ROBBINS, G. F.-(1962) Acta Un. int. Cancr., 18, 864.
ROBINSON, D. W.-(1965) Am. J. Obstet. Gynec., 92, 658.
SLYE, M.-(1933) Am. J. Cancer, 18, 535.
SMITHERS, D. W.-(1948) Br. J. Cancer, 2, 163.
SMITHERS, D. W., RIGBY-JONES, P., GALTON, D. A. G. AND PAYNE, P. M.-(1952) Br.
J. Radiol., Suppl. 4, p. 3.
STEPHENS, F. E., GARDNER, E. J. AND WOOLF, C. M.-(1958) Cancer, N.Y., 11, 967.
STRAX, P., VENET, L. AND SHAPIRO, S.-(1969) Cancer, N. Y., 23, 875.
TAYLOR, G. W. AND WALLACE, W. R. H.-(1947) Surg. Clins N. Am., 27, 1151.
T.N.M. CLASSIFICATION OF MALIGNANT TuMOuRS-(1958) Union Internationale contre
le Cancer, Geneva, p. 39.
TREVES, N. AND HOLLEB, A. I.-(1958) Surgery Gynec. Obstet., 107, 271.
TRUSCOTT, B. M.-(1947) Br. J. Cancer, 1, 129.
URBAN, J. A.-(1959) Cancer, N.Y., 12, 14.
WATSON, T. A.-(1966) Am. J. Roentg., 96, 547.
WHITE, T. T.-(1955) Am. J. Obstet. Gynec., 69, 1277.
WHITE, T. T.-(1955) Surgery Gynec. Obstet., 100. 661.
WHITE, T. T.-(1960) NW. Med., Seattle, 59, 218.
WHITE, T. T. AND WHITE, W. C.-(1956) Ann. Surg., 144, 384.
WOOD, D. A. AND DARLING, H. H.-(1943) (Cancer Res., 3, 509.